glp-1 perte de poids avis Analogue du : médicament pour le diabète et l'obésité Obésité - Le Wegovy commercialisé

The best outcomes are usually achieved when treatment is combined with proper medical guidance, monitoring, and dose optimisation to improve weight loss results and reduce side effects

Ten Bergen LL, Petrovic A, Krogh Aarebrot A, Appel S

WY and A-MX contributed to the conception, design, and revision of the manuscript

December 16, 2020

For the study, researchers evaluated the dermatologic and injection-site reaction safety of GLP-1RAs via a meta-analysis of randomised controlled trials (RCTs) and a disproportionality analysis of data from the United States Food and Drug Administration Adverse Event Reporting System (FAERS)

[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Chung S.D., Liu H.T., Lin H., Kuo H.C